BRL 17421, a novel beta-lactam antibiotic, highly resistant to beta-lactamases, giving high and prolonged serum levels in humans.

BRL 17421 is a new semisynthetic beta-lactam antibiotic with an unusual spectrum of antibacterial activity. The compound exhibits exceptional stability to a wide range of bacterial beta-lactamases and is active against the majority of Enterobacteriaceae, including strains highly resistant to many of...

Popoln opis

Bibliografske podrobnosti

izdano v:	Antimicrob Agents Chemother
Principais autores:	Slocombe, B, Basker, M J, Bentley, P H, Clayton, J P, Cole, M, Comber, K R, Dixon, R A, Edmondson, R A, Jackson, D, Merrikin, D J, Sutherland, R
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Microbiology (ASM) 1981
Teme:	Research Article
Online dostop:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC181629/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6974539/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.20.1.38
Oznake:	Označite Brez oznak, prvi označite!